Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
WORKING PAPERS
March 05, 2024
WORKING PAPERS
February 22, 2024
POLICY PAPERS
March 06, 2024
WORKING PAPERS
February 23, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
WORKING PAPERS
February 23, 2024
As the politics of polarization gain traction and electoral support, a new vintage of populism is emerging in Latin America. This new version shares some aspects with the type of cultural populism now common in advanced economies that divides societies into antagonistic camps. But there are also imp...
CGD NOTES
June 07, 2023
The Committee identifies three critical developments in the global economy with profound implications that require urgent changes at the IMF. This statement advances broad proposals to address these issues by creating an Emerging Markets Fund (EMF); modifying the G20 Common Framework to effectively ...
CGD NOTES
November 21, 2022
Spain’s relationship with Latin America can be mutually beneficial or stale and insignificant. Now, the timing is right for Spain to launch new strategies and a new framework of bilateral, multilateral, and multiregional engagement with the region, in which Spain should embrace its dual role as brid...
CGD NOTES
November 16, 2022
Inflation has become a central feature of the global economy. In Latin America (aside from idiosyncratic cases such as Argentina and Venezuela, where high inflation rates have long been the norm), inflation began to rise the first half of 2021, at the same time it did in the US. The fact that risin...
CGD NOTES
March 03, 2022
The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...